Gotenba, Japan

Noriaki Maruyama

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Shizuoka, JP (2003)
  • Gotenba, JP (2004 - 2009)
  • Tokyo, JP (2012)

Company Filing History:


Years Active: 2003-2012

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Noriaki Maruyama: Innovator in Pharmaceutical Chemistry

Introduction

Noriaki Maruyama is a prominent inventor based in Gotenba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds with therapeutic applications. With a total of 5 patents to his name, Maruyama continues to push the boundaries of scientific research.

Latest Patents

Maruyama's latest patents include a novel process for producing a vitamin D derivative using photoreaction. This process involves irradiating a specific compound with UV light to ring-open the compound, followed by isomerization of the resulting product. Another notable patent is for an indole derivative that possesses COX-2 inhibitory activity, making it useful as a pharmaceutical agent, particularly as an anti-inflammatory treatment.

Career Highlights

Noriaki Maruyama is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work has been instrumental in advancing the company's research initiatives and enhancing its product offerings in the pharmaceutical sector.

Collaborations

Maruyama has collaborated with notable colleagues, including Hiroharu Matsuoka and Nobuaki Kato. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Noriaki Maruyama's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the field. His patents and collaborative efforts continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…